Discover trends, market shifts, and competitive outlooks for the structural heart industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Structural Heart Market, and What Factors Will Drive It?

The size of the structural heart market has seen a solid growth lately. The market, which stands at $14.9 billion in 2024, is projected to expand to $15.99 billion by 2025, with a compound annual growth rate (CAGR) of 7.3%. The surge in growth during the historic phase can be credited to heightened awareness and screening, robust supply chain resilience, a rise in health care spending, market concentration, and a growing consciousness about cardiovascular diseases.

The size of the structural heart market is projected to experience significant expansion over the forthcoming years, with expectations to reach $22.43 billion by the year 2029, encapsulating a compound annual growth rate (CAGR) of 8.8%. Factors contributing to the expansion during the forecast period encompass an escalating demand for heart valve devices, an increasingly aged population, the growing prevalence of cardiovascular conditions, market partitioning, and growth in regional markets. Key trends identified during the forecast period include the introduction of new products, advancements in technology, economic resurgence, regulatory mandates, a surge in cardiovascular disease instances, and the innovation of medical devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What are the Fundamental Drivers and Innovations Shaping the Structural Heart Market?

The escalating cases of cardiovascular maladies are anticipated to drive the expansion of the structural heart market. Cardiovascular conditions, which affect the heart and blood vessels and include diseases like coronary artery disease, heart failure, and stroke, are primarily increasing due to factors like an aging population, lifestyle and dietary changes, and a growth in obesity and diabetes rates. Devices and services for the structural heart provide diagnosis and treatment for disorders impacting the valves, chambers, and surrounding structures of the heart. These treatments are minimally invasive, providing a more efficient solution with fewer risks compared to open-heart surgery. As an illustration, a report by the American College of Cardiology in August 2022 predicted that all four cardiovascular risk factors in the United States would see a rise between 2025 and 2060. The most significant rise is expected in diabetes, increasing by 39.3% to 55 million people, followed by dyslipidemia (increasing by 27.6% to 126 million), hypertension (increasing by 25.1% to 162 million), and obesity (increasing by 18.3% to 126 million). The largest predicted surges in cardiovascular disease rates were identified in stroke (increasing by 33.8% to 15 million) and heart failure (increasing by 33.4% to 13 million), followed by ischemic heart disease (increasing by 30.7% to 29 million) and heart attack (increasing by 16.9% to 16 million). Consequently, the growing cases of cardiovascular conditions are catalyzing the expansion of the structural heart market.

How Is the Structural Heart Market Segmented?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Which Regions Are Driving the Next Phase of the Structural Heart Market Growth?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Structural Heart Market?

The rise in technological innovation is noted as a leading trend within the structural heart market, gaining significant attention. Larger market players in the structural heart sector are focusing on developing novel products to cement their market stance. Notably, in February 2023, Eko Health, a US-based digital health company, introduced the SENSORA platform aimed at detecting cardiac diseases in a non-invasive manner for primary care. The SENSORA platform employs artificial intelligence to precisely identify structural murmurs indicative of valvular heart disease and includes care pathway analytics software that offers insights and measurements for the patient’s passage through the healthcare system by recording and examining heart sounds and electrical signals via its digital stethoscopes. The platform is designed to assist in crucial decision-making by identifying potential care shortcomings that could be translated into increased operational efficiency, such as minimizing delays in care delivery, duration of stay, and readmission rates, whilst improving satisfaction for both patients and physicians.

View the full report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

How Is the Structural Heart Market Defined and What Are Its Core Parameters?

Structural heart refers to a subspecialty within cardiology that focuses on the diagnosis and treatment of structural abnormalities or diseases of the heart, particularly those affecting the valves, chambers, and surrounding structures. It typically involves minimally invasive procedures performed in a catheterization laboratory rather than open-heart surgery.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12029

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model